Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study-Reference-Cited by-同舟云学术

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

Published:2009-11 Issue:11 Volume:10 Page:1063-1069
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Boku Narikazu,Yamamoto Seiichiro,Fukuda Haruhiko,Shirao Kuniaki,Doi Toshihiko,Sawaki Akira,Koizumi Wasaburo,Saito Hiroshi,Yamaguchi Kensei,Takiuchi Hiroya,Nasu Junichiro,Ohtsu Atsushi

Publisher

Elsevier BV

Subject

Oncology

Reference34 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer;Murad;Cancer,1993

3. Initial or delayed chemotherapy with best supportive care in advanced gastric cancer;Glimelius;Ann Oncol,1994

4. Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus best supportive care alone in patients with non-resectable gastric cancer;Pyrhönen;Br J Cancer,1995

5. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma: fluorouracil versus fluorouracil and doxorubicin versus fluorouracil, doxorubicin, and mitomycin;Cullinan;JAMA,1985

Cited by 531 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of concurrent chemoradiotherapy with paclitaxel-based or S-1 regimens in treating elderly patients with esophageal squamous cell carcinoma: A multi-center propensity-score matched study;Translational Oncology;2024-12

2. A real-world survey on expensive drugs used as first-line chemotherapy in patients with HER2-negative unresectable advanced/recurrent gastric cancer in the stomach cancer study group of the Japan clinical oncology group;Japanese Journal of Clinical Oncology;2024-08-24

3. Predicting Tumor Volume Doubling Time and Progression-Free Survival in Untreated Patients from Patient-Derived-Xenograft (PDX) Models: A Translational Model-Based Approach;The AAPS Journal;2024-08-08

4. Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study;CHINESE J CANCER RES;2024

5. Adjuvant and post-recurrent treatment patterns in patients with resectable gastric cancer in Japan: a retrospective database cohort study;Gastric Cancer;2024-04-30